Lurie Cancer Center Support Grant Renewed
Steven T. Rosen, MD, FACP, director of the Robert H. Lurie Cancer Center of Northwestern University, announced that the Center has been awarded a 4-year competitive renewal of its Cancer Center Support Grant (CCSG) from the National
Steven T. Rosen, MD, FACP, director of the Robert H. Lurie Cancer Centerof Northwestern University, announced that the Center has been awardeda 4-year competitive renewal of its Cancer Center Support Grant (CCSG)from the National Cancer Institute. The grant award of $1.47 million peryear supports the cancer research infrastructure of the Lurie Cancer Center.
The Robert H. Lurie Cancer Center of Northwestern University, a NationalCancer Institute-designated clinical cancer center, is the focus of cancerresearch, education, and patient care at Northwestern University. The LurieCancer Center coordinates clinical research and cancer patient care programsat the teaching affiliates of the Northwestern University Medical School,and, through the Northwestern Healthcare Network, is associated with thefollowing hospitals in the Chicago area: Children's Memorial Medical Center,Evanston and Glenbrook Hospitals, Highland Park Hospital, Ingalls HealthSystem, Northwest Community Healthcare, Northwestern Memorial Hospital,Silver Cross Hospital, and Swedish Covenant Hospital.
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
